ArticleActa neurologica Belgica2018

Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

Catherine Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.